Vita Life Sciences Limited (VLS.AX)
AUD 1.78
(0.0%)
AUD 1.78
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 74.16 Million | 66.88 Million | 57.1 Million | 46.48 Million | 42.45 Million | 41.15 Million |
| Cost of Revenue | 31.55 Million | 27.14 Million | 22.29 Million | 17.2 Million | 14.55 Million | 13.51 Million |
| Gross Profit | 42.6 Million | 39.74 Million | 34.8 Million | 29.27 Million | 27.89 Million | 27.64 Million |
| Operating Expenses | 30.38 Million | 29.02 Million | 23.8 Million | 21.72 Million | 23.79 Million | 21.56 Million |
| Selling, General and Administrative Expenses | 30.38 Million | 27.1 Million | 22.21 Million | 20.17 Million | 22.04 Million | 20.21 Million |
| Research and Development Expenses | - | 4000.00 | 9000.00 | 8000.00 | 72 Thousand | 15 Thousand |
| Other Expenses | - | 1.91 Million | 1.58 Million | 1.55 Million | 1.74 Million | -1.77 Million |
| Cost and Expenses | 61.94 Million | 56.16 Million | 46.09 Million | 38.93 Million | 38.34 Million | 35.07 Million |
| Operating Income | 12.21 Million | 10.77 Million | 11.3 Million | 8.32 Million | 4.57 Million | 4.42 Million |
| Interest Expense | 135 Thousand | 34 Thousand | 104 Thousand | 165 Thousand | 146 Thousand | 129 Thousand |
| Income Tax Expense | 3.37 Million | 3.39 Million | 2.95 Million | 2.29 Million | 1.33 Million | 1.89 Million |
| Earnings before Tax | 12.45 Million | 10.73 Million | 11.2 Million | 8.15 Million | 4.42 Million | 4.33 Million |
| Net Income | 9.08 Million | 7.08 Million | 8.29 Million | 6.09 Million | 3.13 Million | 2.43 Million |
| Earnings Per Share Basic | 0.17 | 0.13 | 0.16 | 0.12 | 0.06 | 0.04 |
| Earnings Per Share Diluted | 0.17 | 0.13 | 0.16 | 0.12 | 0.06 | 0.04 |
| Weighted Average Shares Outstanding | 53.66 Million | 52.96 Million | 52.63 Million | 52.61 Million | 54.76 Million | 54.9 Million |
| Weighted Average Shares Outstanding (Diluted) | 54.69 Million | 53.99 Million | 53.12 Million | 52.61 Million | 54.76 Million | 54.9 Million |
| Gross Margin | 0.57 | 0.59 | 0.61 | 0.63 | 0.66 | 0.67 |
| EBIT Margin | 0.18 | 0.17 | 0.21 | 0.19 | 0.12 | 0.12 |
| Profit Margin | 0.12 | 0.11 | 0.15 | 0.13 | 0.07 | 0.06 |
| EBITDA | 13.09 Million | 11.37 Million | 11.71 Million | 8.87 Million | 5.15 Million | 4.83 Million |
| Earnings Before Tax Margin | 0.16 | 0.16 | 0.20 | 0.18 | 0.11 | 0.11 |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | 39.45 Million | 74.16 Million | 39.46 Million | 34.69 Million | 34.15 Million | 66.88 Million |
| Cost of Revenue | 16.46 Million | 31.55 Million | 16.54 Million | 15.01 Million | 13.99 Million | 27.14 Million |
| Gross Profit | 22.98 Million | 42.6 Million | 22.92 Million | 19.68 Million | 20.15 Million | 39.74 Million |
| Operating Expenses | 17.08 Million | 30.38 Million | 16.2 Million | 14.18 Million | 14.64 Million | 29.02 Million |
| Selling, General and Administrative Expenses | 17.08 Million | - | 16.2 Million | 14.18 Million | 14.64 Million | - |
| Research and Development Expenses | - | - | 17 Thousand | - | 4000.00 | - |
| Other Expenses | - | 152 Thousand | - | - | - | 1.91 Million |
| Cost and Expenses | 33.55 Million | 61.94 Million | 32.75 Million | 29.19 Million | 28.64 Million | 56.16 Million |
| Operating Income | 5.89 Million | 12.21 Million | 6.71 Million | 5.49 Million | 5.5 Million | 10.77 Million |
| Interest Expense | 101 Thousand | 135 Thousand | 127 Thousand | 8000.00 | - | 34 Thousand |
| Income Tax Expense | 1.72 Million | 3.37 Million | 1.86 Million | 1.51 Million | 1.7 Million | 3.39 Million |
| Earnings before Tax | 6.01 Million | 12.45 Million | 6.95 Million | 5.49 Million | 5.41 Million | 10.73 Million |
| Net Income | 4.29 Million | 9.08 Million | 5.09 Million | 3.98 Million | 3.43 Million | 7.08 Million |
| Earnings Per Share Basic | 0.08 | - | 0.09 | 0.07 | 0.06 | - |
| Earnings Per Share Diluted | 0.08 | - | 0.09 | 0.07 | 0.06 | - |
| Weighted Average Shares Outstanding | 54.99 Million | 53.66 Million | 56.4 Million | 53.68 Million | 56.52 Million | 52.96 Million |
| Weighted Average Shares Outstanding (Diluted) | 54.99 Million | 54.69 Million | 56.4 Million | 54.71 Million | 56.52 Million | 53.99 Million |
| Gross Margin | 0.58 | 0.57 | 0.58 | 0.57 | 0.59 | 0.59 |
| EBIT Margin | 0.14 | - | 0.18 | 0.17 | 0.17 | - |
| Profit Margin | 0.11 | 0.12 | 0.13 | 0.11 | 0.10 | 0.11 |
| EBITDA | 5.68 Million | - | 6.96 Million | 5.76 Million | 5.89 Million | - |
| Earnings Before Tax Margin | 0.15 | 0.16 | 0.17 | 0.16 | 0.16 | 0.16 |
BGO
CWBR
LSEAW
6247
FAXXF
000063